NEW RHEIN HEALTHCARE INVESTORS LLC
Adviser information for NEW RHEIN HEALTHCARE INVESTORS LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 9 |
|---|---|
| Investment Advisory/Research | 6 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 1 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 5 | $229.6M |
| Non-Discretionary | 0 | $0 |
| Total | 5 | $229.6M |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 5 | $229.6M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 80 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
Identifiers
| SEC RIA File Number | 801-124768 |
|---|---|
| SEC ERA File Number | 801-124768 |
| SEC CIK Numbers | None |
| SEC CRD Numbers | 300842 |
| Legal Entity Identifier | None |
Principal Office
TWO LOGAN SQUARE100 N. 18TH STREET, SUITE 1930
PHILADELPHIA
PA
United States
Monday - Friday, 8AM - 4PM CET
Tel: (201) 674-9387, Fax: None
Chief Compliance Officer
SUBHANU SAXENA
MANAGING PARTNER
TWO LOGAN SQUARE
100 N. 18TH STREET, SUITE 1930
PHILADELPHIA
PA
United States
Tel:
(+44) 7712 225168
S******@***********M
(Full email address available in API data)
Regulatory Contact
ROBERT CZESAK
CHIEF FINANCIAL OFFICER
TWO LOGAN SQUARE
100 N. 18TH STREET, SUITE 1930
PHILADELPHIA
PA
United States
Tel:
201-674-9387
R**@***********M
(Full email address available in API data)
Industry Affiliates
| NEW RHEIN HEALTHCARE 18 CIP LP | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN HEALTHCARE 18 GP SARL | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN HEALTHCARE 2021 GP SARL | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN HEALTHCARE 2021 CIP LP | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN HEALTHCARE INVESTORS BV | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN UK LLP | Sponsor, GP, manager of pooled investment vehicles |
| NEW RHEIN UK LTD | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| NEW RHEIN HEALTHCARE 18 (PARALLEL) SCSP | Venture Capital Fund | $30.1M | $0.1M | 8 |
| NEW RHEIN HEALTHCARE 18 LP | Venture Capital Fund | $40.7M | $0.1M | 21 |
| NEW RHEIN HEALTHCARE 2021 (DE) LP | Venture Capital Fund | $19.0M | $1.0M | 26 |
| NEW RHEIN HEALTHCARE 2021 (LUX) SCSP | Venture Capital Fund | $34.5M | $1.0M | 19 |
| NEW RHEIN HEALTHCARE 2021 PRIVAK | Venture Capital Fund | $20.3M | $0.1M | 7 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| PAREKH, NAYAN, GREG | Individual | – | FOUNDER & MANAGING PARTNER | 04/2018 | > 75% |
| GERGEL, IVAN, PHILIP | Individual | – | MANAGING PARTNER & CHIEF MEDICAL OFFICER | 04/2018 | < 5% |
| SAXENA, SUBHANU | Individual | – | MANAGING PARTNER & CHIEF COMPLIANCE OFFICER | 04/2018 | < 5% |
| CZESAK, ROBERT, WILLIAM | Individual | – | CHIEF FINANCIAL OFFICER | 12/2023 | < 5% |